Pradip De Selected Research

SF 1126

4/2013	An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.
1/2008	A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pradip De Research Topics

Disease

38	Neoplasms (Cancer) 06/2022 - 12/2007
13	Breast Neoplasms (Breast Cancer) 06/2022 - 08/2013
5	Triple Negative Breast Neoplasms 01/2017 - 01/2013
4	Carcinogenesis 01/2021 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2013
2	Disease Progression 01/2018 - 07/2017
1	Endometriosis 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Shock 11/2020
1	Carcinoma (Carcinomatosis) 01/2017
1	Neoplastic Cell Transformation 07/2014

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 07/2014
5	Phosphotransferases (Kinase)IBA 06/2022 - 03/2008
5	IntegrinsIBA 01/2017 - 01/2008
4	beta CateninIBA 01/2021 - 01/2013
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 10/2013
4	Estrogen ReceptorsIBA 01/2019 - 11/2016
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
3	pertuzumabIBA 01/2020 - 10/2013
2	Circulating Tumor DNAIBA 10/2021 - 01/2017
2	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 01/2021 - 01/2014
2	Guanosine Triphosphate (GTP)IBA 06/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2017
2	Everolimus FDA Link 01/2019 - 06/2017
2	palbociclibIBA 01/2019 - 06/2017
2	Protein Isoforms (Isoforms)IBA 01/2019 - 04/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 07/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2017 - 01/2014
2	Monomeric GTP-Binding ProteinsIBA 01/2017 - 12/2007
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 07/2016 - 01/2014
2	Epidermal Growth Factor (EGF)IBA 06/2015 - 12/2013
2	NexusIBA 01/2015 - 07/2014
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015 - 11/2009
2	Neuregulin-1 (Neuregulin 1)IBA 01/2015 - 10/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2015 - 07/2014
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014 - 01/2008
2	CateninsIBA 11/2013 - 01/2013
2	SF 1126IBA 04/2013 - 01/2008
2	Biological ProductsIBA 03/2008 - 12/2007
1	CyclinsIBA 06/2022
1	Cyclin DIBA 06/2022
1	ElementsIBA 03/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 06/2020
1	rac1 GTP-Binding ProteinIBA 06/2020
1	tucatinibIBA 01/2020
1	taxaneIBA 01/2020
1	margetuximabIBA 01/2020
1	trastuzumab deruxtecanIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Nucleosomes (Nucleosome)IBA 11/2019
1	ribociclibIBA 01/2019
1	abemaciclibIBA 01/2019
1	venetoclaxIBA 01/2019
1	AlpelisibIBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019
1	Aromatase InhibitorsIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	PhosphatidylserinesIBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018
1	CaspasesIBA 01/2018
1	Letrozole (Femara)FDA LinkGeneric 06/2017
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	beta-Aminoethyl Isothiourea (AET)IBA 11/2016
1	sulindac sulfideIBA 07/2016
1	matrigelIBA 07/2016
1	Caseins (Casein)FDA Link 07/2016
1	Angiogenesis InhibitorsIBA 01/2016
1	dactolisibIBA 01/2016
1	Estrogens (Estrogen)FDA Link 06/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	LigandsIBA 01/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	veliparibIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Carboplatin (JM8)FDA LinkGeneric 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014
1	Sirolimus (Rapamycin)FDA Link 01/2014
1	Fibronectins (Fibronectin)IBA 11/2013
1	ParaffinIBA 11/2013
1	Formaldehyde (Formol)FDA Link 11/2013
1	Sulfides (Thioethers)IBA 11/2013
1	Actins (F Actin)IBA 11/2013
1	Small Interfering RNA (siRNA)IBA 11/2013

Therapy/Procedure

23	Therapeutics 06/2022 - 04/2013
5	Precision Medicine 06/2022 - 07/2017
4	Drug Therapy (Chemotherapy) 06/2022 - 07/2017
1	Pacifiers 10/2021
1	Secondary Prevention 10/2021
1	Neoadjuvant Therapy 01/2021
1	Critical Care (Surgical Intensive Care) 11/2020